2019 Q3 Form 10-Q Financial Statement

#000117184319005405 Filed on August 12, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q2
Revenue $3.317M $3.279M $3.886M
YoY Change -0.81% -15.61% 2.94%
Cost Of Revenue $1.387M $1.467M $1.537M
YoY Change 15.83% -4.52% -7.81%
Gross Profit $1.930M $1.812M $2.349M
YoY Change -10.08% -22.86% 11.45%
Gross Profit Margin 58.19% 55.26% 60.45%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $104.8K $93.85K $91.29K
YoY Change 6.61% 2.81% -42.33%
% of Gross Profit 5.43% 5.18% 3.89%
Depreciation & Amortization $50.00K $40.00K $50.00K
YoY Change 25.0% -20.0% 0.0%
% of Gross Profit 2.59% 2.21% 2.13%
Operating Expenses $104.8K $502.1K $534.4K
YoY Change -79.82% -6.05% 27.67%
Operating Profit $1.281M $1.216M $1.723M
YoY Change -16.21% -29.43% 12.58%
Interest Expense $70.00K $140.0K $40.00K
YoY Change -50.0% 250.0% -42.86%
% of Operating Profit 5.46% 11.51% 2.32%
Other Income/Expense, Net $72.82K $136.8K $39.52K
YoY Change -46.92% 246.12% -45.71%
Pretax Income $1.354M $1.353M $1.763M
YoY Change -18.74% -23.25% 9.93%
Income Tax $284.4K $274.1K $370.2K
% Of Pretax Income 21.0% 20.26% 21.0%
Net Earnings $1.070M $1.079M $1.393M
YoY Change -18.74% -22.54% 26.13%
Net Earnings / Revenue 32.25% 32.9% 35.84%
Basic Earnings Per Share
Diluted Earnings Per Share $233.1K $235.3K $302.8K
COMMON SHARES
Basic Shares Outstanding 4.594M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.540M $8.600M $8.680M
YoY Change -4.02% -0.92% -20.95%
Cash & Equivalents $1.795M $910.7K $3.856M
Short-Term Investments $7.740M $7.690M $4.820M
Other Short-Term Assets $270.0K $260.0K $200.0K
YoY Change 80.0% 30.0% 0.0%
Inventory $1.274M $1.301M $1.500M
Prepaid Expenses
Receivables $1.619M $1.533M $2.152M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.70M $11.70M $12.53M
YoY Change -4.1% -6.62% -11.33%
LONG-TERM ASSETS
Property, Plant & Equipment $814.1K $782.8K $882.1K
YoY Change -5.75% -11.26% -11.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $18.53K $22.24K $37.06K
YoY Change -44.44% -40.0% -28.57%
Total Long-Term Assets $832.6K $805.0K $919.1K
YoY Change -7.19% -12.41% -12.61%
TOTAL ASSETS
Total Short-Term Assets $12.70M $11.70M $12.53M
Total Long-Term Assets $832.6K $805.0K $919.1K
Total Assets $13.53M $12.50M $13.45M
YoY Change -4.3% -7.02% -11.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $307.8K $90.45K $473.3K
YoY Change 150.33% -80.89% 453.8%
Accrued Expenses $1.081M $1.364M $1.268M
YoY Change 9.1% 7.55% 24.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.529M $1.595M $1.893M
YoY Change 22.3% -15.76% 42.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.529M $1.595M $1.893M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.760M $1.800M $1.890M
YoY Change 38.58% -4.76% 35.0%
SHAREHOLDERS EQUITY
Retained Earnings $11.31M $10.24M $11.09M
YoY Change -8.86% -7.68% -14.64%
Common Stock $459.4K $459.4K $459.4K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.77M $10.70M $11.55M
YoY Change
Total Liabilities & Shareholders Equity $13.53M $12.50M $13.45M
YoY Change -4.3% -7.02% -11.42%

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income $1.070M $1.079M $1.393M
YoY Change -18.74% -22.54% 26.13%
Depreciation, Depletion And Amortization $50.00K $40.00K $50.00K
YoY Change 25.0% -20.0% 0.0%
Cash From Operating Activities $990.0K $1.110M $1.050M
YoY Change -16.81% 5.71% -8.7%
INVESTING ACTIVITIES
Capital Expenditures -$70.00K -$20.00K -$10.00K
YoY Change 133.33% 100.0%
Acquisitions
YoY Change
Other Investing Activities -$20.00K $1.840M $4.050M
YoY Change -99.53% -54.57% 1660.87%
Cash From Investing Activities -$100.0K $1.820M $4.030M
YoY Change -97.69% -54.84% 1652.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -2.520M -2.290M
YoY Change 10.04% 18.65%
NET CHANGE
Cash From Operating Activities 990.0K 1.110M 1.050M
Cash From Investing Activities -100.0K 1.820M 4.030M
Cash From Financing Activities 0.000 -2.520M -2.290M
Net Change In Cash 890.0K 410.0K 2.790M
YoY Change -128.34% -85.3% -607.27%
FREE CASH FLOW
Cash From Operating Activities $990.0K $1.110M $1.050M
Capital Expenditures -$70.00K -$20.00K -$10.00K
Free Cash Flow $1.060M $1.130M $1.060M
YoY Change -13.11% 6.6% -7.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Type
DocumentType
10-Q
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4594319
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock
CY2019Q2 ug Accrued Annual Report Expenses Current
AccruedAnnualReportExpensesCurrent
36179
CY2018Q4 ug Accrued Annual Report Expenses Current
AccruedAnnualReportExpensesCurrent
66618
CY2019Q2 ug Accrued Computer Services Current
AccruedComputerServicesCurrent
1442
CY2018Q4 ug Accrued Computer Services Current
AccruedComputerServicesCurrent
16593
CY2019Q2 ug Accrued Distribution Fees Current
AccruedDistributionFeesCurrent
325675
CY2018Q4 ug Accrued Distribution Fees Current
AccruedDistributionFeesCurrent
315242
CY2019Q2 ug Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
214897
CY2018Q4 ug Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
160533
ug Cost Of Equipment Traded In Net
CostOfEquipmentTradedInNet
ug Cost Of Equipment Traded In Net
CostOfEquipmentTradedInNet
39837
CY2019Q2 ug Debt Securities Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost
7342773
CY2018Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost
7369633
CY2019Q2 ug Debt Securities Held To Maturity And Equity Securities Fvni Fair Value
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue
7691880
CY2018Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Fair Value
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue
7622196
CY2019Q2 ug Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss
349107
CY2018Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss
252563
CY2019Q2 ug Dividends Not Paid
DividendsNotPaid
1930
CY2018Q2 ug Dividends Not Paid
DividendsNotPaid
-5867
CY2019Q2 ug Dividends Paid
DividendsPaid
2524946
CY2018Q2 ug Dividends Paid
DividendsPaid
-2291294
CY2019Q2 ug Equity Securities Fvni Accumulated Unrealized Gain Loss
EquitySecuritiesFvniAccumulatedUnrealizedGainLoss
349107
CY2018Q4 ug Equity Securities Fvni Accumulated Unrealized Gain Loss
EquitySecuritiesFvniAccumulatedUnrealizedGainLoss
252563
CY2019Q2 ug Gain Loss From Trade In Of Equipment
GainLossFromTradeInOfEquipment
CY2018Q2 ug Gain Loss From Trade In Of Equipment
GainLossFromTradeInOfEquipment
ug Gain Loss From Trade In Of Equipment
GainLossFromTradeInOfEquipment
ug Gain Loss From Trade In Of Equipment
GainLossFromTradeInOfEquipment
-12837
CY2018Q1 ug Reclassification Of Unrealized Gain Loss On Securities From Aoci To Retained Earnings
ReclassificationOfUnrealizedGainLossOnSecuritiesFromAOCIToRetainedEarnings
CY2019Q2 ug Revenue From Contract With Customer Including Assessed Tax Gross
RevenueFromContractWithCustomerIncludingAssessedTaxGross
3279399
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3131368
CY2018Q2 ug Revenue From Contract With Customer Including Assessed Tax Gross
RevenueFromContractWithCustomerIncludingAssessedTaxGross
3885887
ug Revenue From Contract With Customer Including Assessed Tax Gross
RevenueFromContractWithCustomerIncludingAssessedTaxGross
6459716
ug Revenue From Contract With Customer Including Assessed Tax Gross
RevenueFromContractWithCustomerIncludingAssessedTaxGross
7322151
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
90452
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
186797
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1533255
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1672567
CY2019Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
431545
CY2018Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
242000
CY2019Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
52894
CY2018Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1363766
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1040635
CY2019Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
16200
CY2018Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
15000
CY2019Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
35000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
43668
CY2019Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
153261
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
159385
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6525629
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6448831
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
16895
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
16895
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
16895
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
16895
CY2019Q2 us-gaap Assets
Assets
12502944
CY2018Q4 us-gaap Assets
Assets
12544672
CY2019Q2 us-gaap Assets Current
AssetsCurrent
11697927
CY2018Q4 us-gaap Assets Current
AssetsCurrent
11687100
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0; text-align: right"></td> <td style="width: 27pt"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></td> <td style="text-align: justify">Basis of Presentation</td> </tr> </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 27pt">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 27pt">Interim condensed financial statements of the Company are prepared in accordance with United States Generally Accepted Accounting Principles (&#x201c;US GAAP&#x201d;) for interim financial information, pursuant to the requirements for reporting on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q and Regulation S-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">X.</div> In the opinion of management, all adjustments, including normal recurring accruals, considered necessary for the fair presentation of financial statements for the interim periods have been included. The results of operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019 (</div>also referred to as the "second quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019"</div> and the "first half of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019",</div> respectively) are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of results that ultimately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be achieved for any other interim period or for the year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019. </div>The interim unaudited condensed financial statements and notes thereto should be read in conjunction with the audited financial statements and notes thereto contained in our Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018. </div>Unless indicated otherwise, references herein to &#x201c;Sales&#x201d; or &#x201c;sales&#x201d;, shall refer to net sales. When changes are shown as percentages, the number is approximate, and has been rounded from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> decimal place to the nearest whole number.</div></div>
CY2019Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2827195
CY2018Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2801582
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
910705
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
550135
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
724721
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3856089
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
360570
CY2019Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
701000
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
313000
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.55
CY2018Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.50
CY2019Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.55
CY2018Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4594319
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4594319
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4594319
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4594319
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
459432
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
459432
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1467323
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1536842
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2755668
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2904525
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
2063263
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
2162547
us-gaap Costs And Expenses
CostsAndExpenses
3997228
us-gaap Costs And Expenses
CostsAndExpenses
4156008
CY2019Q2 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
330044
CY2018Q2 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
374032
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
644207
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
684150
CY2019Q2 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
86849
CY2018Q2 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-18256
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
344043
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-153406
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
247499
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-113276
CY2019Q2 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
252728
CY2018Q2 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-113276
CY2019Q2 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-165879
CY2018Q2 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
95020
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
96544
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-40130
CY2019Q2 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-55928
CY2018Q2 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3833
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-45072
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-32215
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-45072
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-32215
CY2019Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
208511
CY2018Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
253583
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
84210
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
95956
CY2019Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
140649
CY2018Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
138719
CY2019Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1930
CY2018Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5867
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.23
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.30
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.50
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.53
CY2019Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
2988118
CY2018Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
3879515
CY2019Q2 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
2639011
CY2018Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
3626952
CY2019Q2 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
4412216
CY2018Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
4406174
CY2019Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
4703762
CY2018Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
3742681
CY2019Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
4703762
CY2018Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3742681
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1352926
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1762861
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2900639
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3104459
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
70452
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
274116
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
370199
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
599135
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
651935
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
475000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
725000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-96345
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
119052
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-139312
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
246534
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-40849
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
323131
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
386717
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-181360
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
159846
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24695
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-169207
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
0
CY2019Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
838985
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
984252
CY2019Q2 us-gaap Inventory Net
InventoryNet
1300791
CY2018Q4 us-gaap Inventory Net
InventoryNet
1482151
CY2019Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
416629
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
467842
CY2019Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
20000
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
20000
CY2019Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
45177
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
30057
CY2019Q2 us-gaap Investment Income Net
InvestmentIncomeNet
49941
CY2018Q2 us-gaap Investment Income Net
InvestmentIncomeNet
57777
us-gaap Investment Income Net
InvestmentIncomeNet
94108
us-gaap Investment Income Net
InvestmentIncomeNet
104559
CY2019Q2 us-gaap Land
Land
69000
CY2018Q4 us-gaap Land
Land
69000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12502944
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12544672
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1594867
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1366151
CY2019Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7691880
CY2018Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7622196
CY2019Q2 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
86849
CY2018Q2 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-18256
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
344043
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-153406
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
344043
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-153406
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2524946
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2291294
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
242704
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2706309
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2642812
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2716353
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1222694
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
1078810
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
1059862
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
1392662
us-gaap Net Income Loss
NetIncomeLoss
2301504
us-gaap Net Income Loss
NetIncomeLoss
2452524
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
136790
us-gaap Operating Expenses
OperatingExpenses
1049056
us-gaap Operating Expenses
OperatingExpenses
1058534
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1216136
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1723340
us-gaap Operating Income Loss
OperatingIncomeLoss
2462488
us-gaap Operating Income Loss
OperatingIncomeLoss
3166143
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
39521
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
438151
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-61684
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
502094
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
534420
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21673
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21596
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22235
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29647
us-gaap Payments Of Dividends
PaymentsOfDividends
2524946
us-gaap Payments Of Dividends
PaymentsOfDividends
2291294
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
9085612
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1350509
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31655
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40552
CY2019Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
75000
CY2018Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
229816
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
159364
CY2019Q2 us-gaap Prepaid Taxes
PrepaidTaxes
31480
CY2018Q4 us-gaap Prepaid Taxes
PrepaidTaxes
200687
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
827925
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9359971
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
4097370
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7308411
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7276756
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
782782
us-gaap Reclassifications
Reclassifications
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0; text-align: right"></td> <td style="width: 27pt"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.</div></td> <td style="text-align: justify">Reclassifications</td> </tr> </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 27pt">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 27pt">Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. These reclassifications had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on the previously reported net income.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 27pt">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 27pt">In accordance with ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> &#x201c;Revenue from Contracts with Customers&#x201d;, for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>the Company reclassified certain sales rebates from Cost of Sales to Net Sales, in the amounts of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$73,330</div></div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$156,579</div>,</div> respectively. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2019, </div>the Company reclassified certain sales rebates from Cost of Sales to Net Sales in the amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">101,706</div></div></div>,</div> which impacted the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2019 </div>by that same amount. The reclassification had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on gross profit, net income, the provision for income taxes or earnings per share for either period. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div> for further discussion regarding ASU Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606.</div></div></div>
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
93846
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
91285
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
192504
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
192949
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10240134
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10465506
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3279399
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3885887
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6459716
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7322151
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
10924938
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
12147632
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
10699566
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
11396642
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
12456504
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
11552005
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319

Files In Submission

Name View Source Status
0001171843-19-005405-index-headers.html Edgar Link pending
0001171843-19-005405-index.html Edgar Link pending
0001171843-19-005405.txt Edgar Link pending
0001171843-19-005405-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_32.htm Edgar Link pending
f10q_081219p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ug-20190630.xml Edgar Link completed
ug-20190630.xsd Edgar Link pending
ug-20190630_cal.xml Edgar Link unprocessable
ug-20190630_def.xml Edgar Link unprocessable
ug-20190630_lab.xml Edgar Link unprocessable
ug-20190630_pre.xml Edgar Link unprocessable